子宫内膜癌中分离肿瘤细胞、微转移和大转移的组织学特异性预后意义

IF 4.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Gynecologic oncology Pub Date : 2025-03-01 Epub Date: 2025-02-17 DOI:10.1016/j.ygyno.2025.02.012
Koji Matsuo , Joel Agarwal , Ling Chen , Katelyn B. Furey , Bonnie B. Song , Christian Pino , Shinya Matsuzaki , Yukio Suzuki , Maximilian Klar , Lynda D. Roman , Jason D. Wright
{"title":"子宫内膜癌中分离肿瘤细胞、微转移和大转移的组织学特异性预后意义","authors":"Koji Matsuo ,&nbsp;Joel Agarwal ,&nbsp;Ling Chen ,&nbsp;Katelyn B. Furey ,&nbsp;Bonnie B. Song ,&nbsp;Christian Pino ,&nbsp;Shinya Matsuzaki ,&nbsp;Yukio Suzuki ,&nbsp;Maximilian Klar ,&nbsp;Lynda D. Roman ,&nbsp;Jason D. Wright","doi":"10.1016/j.ygyno.2025.02.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To examine the association between regional lymph node status based on metastatic size and anatomical location and survival per histology in endometrial cancer.</div></div><div><h3>Methods</h3><div>This retrospective study queried the Commission-on-Cancer's National Cancer Database. Study population included 87,904 patients with stage I-III endometrial cancer from 2018 to 2021. Multivariable Cox proportional hazard regression models were created to assess overall survival per histology (non-endometrioid / high-grade endometrioid or low-grade endometrioid).</div></div><div><h3>Results</h3><div>In both histology groups, comparing to pelvic micro-metastasis, macro-metastasis regardless of anatomical location (pelvic / para-aortic) was associated with decreased overall survival (non-endometrioid / high-grade endometrioid histology, adjusted-hazard ratio [aHR] 1.31, 95% confidence interval [CI] 1.08–1.59/aHR 1.39, 95%CI 1.13–1.72; and low-grade endometrioid histology, aHR 1.68, 95%CI 1.19–2.36 / aHR 1.78, 95%CI 1.10–2.88) while para-aortic micro-metastases had overall survival similar to pelvic micro-metastasis. Survival effects of macro-metastasis were larger in low-grade endometrioid compared to non-endometrioid / high-grade endometrioid histology (aHR range, 1.68–1.78 vs 1.31–1.39). For non-endometrioid / high-grade endometrioid histology, isolated tumor cells were associated with better overall survival compared to pelvic micro-metastasis (aHR 0.62, 95%CI 0.45–0.85); isolated tumor cells and negative nodal metastasis had similar overall survival (aHR 1.05, 95%CI 0.80–1.38). Contrary, in low-grade endometrioid histology, isolated tumor cells were associated with decreased overall survival compared to negative-node (aHR 1.55, 95%CI 1.18–2.04); isolated tumor cells had overall survival similar to pelvic micro-metastasis (aHR 0.83, 95%CI 0.56–1.24).</div></div><div><h3>Conclusion</h3><div>The results of this cohort study suggest that tumor metastatic size may be more prognostic than anatomical location in endometrial cancer. Histology-specific interaction of isolated tumor cells warrants further investigation, especially in low-grade endometrioid histology.</div></div>","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":"194 ","pages":"Pages 51-59"},"PeriodicalIF":4.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer\",\"authors\":\"Koji Matsuo ,&nbsp;Joel Agarwal ,&nbsp;Ling Chen ,&nbsp;Katelyn B. Furey ,&nbsp;Bonnie B. Song ,&nbsp;Christian Pino ,&nbsp;Shinya Matsuzaki ,&nbsp;Yukio Suzuki ,&nbsp;Maximilian Klar ,&nbsp;Lynda D. Roman ,&nbsp;Jason D. Wright\",\"doi\":\"10.1016/j.ygyno.2025.02.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>To examine the association between regional lymph node status based on metastatic size and anatomical location and survival per histology in endometrial cancer.</div></div><div><h3>Methods</h3><div>This retrospective study queried the Commission-on-Cancer's National Cancer Database. Study population included 87,904 patients with stage I-III endometrial cancer from 2018 to 2021. Multivariable Cox proportional hazard regression models were created to assess overall survival per histology (non-endometrioid / high-grade endometrioid or low-grade endometrioid).</div></div><div><h3>Results</h3><div>In both histology groups, comparing to pelvic micro-metastasis, macro-metastasis regardless of anatomical location (pelvic / para-aortic) was associated with decreased overall survival (non-endometrioid / high-grade endometrioid histology, adjusted-hazard ratio [aHR] 1.31, 95% confidence interval [CI] 1.08–1.59/aHR 1.39, 95%CI 1.13–1.72; and low-grade endometrioid histology, aHR 1.68, 95%CI 1.19–2.36 / aHR 1.78, 95%CI 1.10–2.88) while para-aortic micro-metastases had overall survival similar to pelvic micro-metastasis. Survival effects of macro-metastasis were larger in low-grade endometrioid compared to non-endometrioid / high-grade endometrioid histology (aHR range, 1.68–1.78 vs 1.31–1.39). For non-endometrioid / high-grade endometrioid histology, isolated tumor cells were associated with better overall survival compared to pelvic micro-metastasis (aHR 0.62, 95%CI 0.45–0.85); isolated tumor cells and negative nodal metastasis had similar overall survival (aHR 1.05, 95%CI 0.80–1.38). Contrary, in low-grade endometrioid histology, isolated tumor cells were associated with decreased overall survival compared to negative-node (aHR 1.55, 95%CI 1.18–2.04); isolated tumor cells had overall survival similar to pelvic micro-metastasis (aHR 0.83, 95%CI 0.56–1.24).</div></div><div><h3>Conclusion</h3><div>The results of this cohort study suggest that tumor metastatic size may be more prognostic than anatomical location in endometrial cancer. Histology-specific interaction of isolated tumor cells warrants further investigation, especially in low-grade endometrioid histology.</div></div>\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":\"194 \",\"pages\":\"Pages 51-59\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825825000484\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825825000484","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的探讨子宫内膜癌中基于转移大小和解剖位置的区域淋巴结状态与组织学生存的关系。方法:本回顾性研究查询了癌症委员会的国家癌症数据库。研究人群包括87,904例2018年至2021年的I-III期子宫内膜癌患者。建立多变量Cox比例风险回归模型来评估每种组织学(非子宫内膜样/高级别子宫内膜样或低级别子宫内膜样)的总生存率。结果在两组组织学中,与盆腔微转移相比,不论解剖位置(盆腔/主动脉旁)的大转移与总生存率降低相关(非子宫内膜样/高级别子宫内膜样组织学,调整风险比[aHR] 1.31, 95%可信区间[CI] 1.08-1.59 /aHR 1.39, 95%可信区间[CI] 1.13-1.72;低级别子宫内膜样组织(aHR 1.68, 95%CI 1.19-2.36 / aHR 1.78, 95%CI 1.10-2.88),而主动脉旁微转移的总生存率与盆腔微转移相似。与非子宫内膜样/高级别子宫内膜样组织相比,低级别子宫内膜样组织中大转移的生存效应更大(aHR范围,1.68-1.78 vs 1.31-1.39)。对于非子宫内膜样/高度子宫内膜样组织学,与盆腔微转移相比,分离的肿瘤细胞具有更好的总生存率(aHR 0.62, 95%CI 0.45-0.85);分离的肿瘤细胞和阴性淋巴结转移的总体生存率相似(aHR 1.05, 95%CI 0.80-1.38)。相反,在低级别子宫内膜样组织中,与阴性结相比,分离的肿瘤细胞与总生存率降低相关(aHR 1.55, 95%CI 1.18-2.04);分离肿瘤细胞的总生存率与盆腔微转移相似(aHR 0.83, 95%CI 0.56-1.24)。结论本队列研究结果提示,子宫内膜癌的肿瘤转移大小可能比解剖位置更能影响预后。分离肿瘤细胞的组织学特异性相互作用值得进一步研究,特别是在低级别子宫内膜样组织学中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer

Objective

To examine the association between regional lymph node status based on metastatic size and anatomical location and survival per histology in endometrial cancer.

Methods

This retrospective study queried the Commission-on-Cancer's National Cancer Database. Study population included 87,904 patients with stage I-III endometrial cancer from 2018 to 2021. Multivariable Cox proportional hazard regression models were created to assess overall survival per histology (non-endometrioid / high-grade endometrioid or low-grade endometrioid).

Results

In both histology groups, comparing to pelvic micro-metastasis, macro-metastasis regardless of anatomical location (pelvic / para-aortic) was associated with decreased overall survival (non-endometrioid / high-grade endometrioid histology, adjusted-hazard ratio [aHR] 1.31, 95% confidence interval [CI] 1.08–1.59/aHR 1.39, 95%CI 1.13–1.72; and low-grade endometrioid histology, aHR 1.68, 95%CI 1.19–2.36 / aHR 1.78, 95%CI 1.10–2.88) while para-aortic micro-metastases had overall survival similar to pelvic micro-metastasis. Survival effects of macro-metastasis were larger in low-grade endometrioid compared to non-endometrioid / high-grade endometrioid histology (aHR range, 1.68–1.78 vs 1.31–1.39). For non-endometrioid / high-grade endometrioid histology, isolated tumor cells were associated with better overall survival compared to pelvic micro-metastasis (aHR 0.62, 95%CI 0.45–0.85); isolated tumor cells and negative nodal metastasis had similar overall survival (aHR 1.05, 95%CI 0.80–1.38). Contrary, in low-grade endometrioid histology, isolated tumor cells were associated with decreased overall survival compared to negative-node (aHR 1.55, 95%CI 1.18–2.04); isolated tumor cells had overall survival similar to pelvic micro-metastasis (aHR 0.83, 95%CI 0.56–1.24).

Conclusion

The results of this cohort study suggest that tumor metastatic size may be more prognostic than anatomical location in endometrial cancer. Histology-specific interaction of isolated tumor cells warrants further investigation, especially in low-grade endometrioid histology.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Gynecologic oncology
Gynecologic oncology 医学-妇产科学
CiteScore
8.60
自引率
6.40%
发文量
1062
审稿时长
37 days
期刊介绍: Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published. Research Areas Include: • Cell and molecular biology • Chemotherapy • Cytology • Endocrinology • Epidemiology • Genetics • Gynecologic surgery • Immunology • Pathology • Radiotherapy
期刊最新文献
A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies Cost-effectiveness of pembrolizumab as a treatment for FIGO 2014 stage III–IVA cervical cancer in the United States Multimodal prehabilitation in patients with advanced ovarian cancer The impact of multimodal prehabilitation on surgical outcomes in gynaecological cancer surgery Uptake of risk-reducing medical interventions among female BRCA1/2 pathogenic variant carriers: A population-based study in British Columbia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1